New prostate drug tested in healthy men: safety first
NCT ID NCT07404735
First seen Feb 11, 2026 · Last updated May 19, 2026 · Updated 11 times
Summary
This early-stage trial tests a new drug called CKD-846 in 32 healthy men with benign prostate hypertrophy (BPH). The goal is to see how the drug moves through the body and if it is safe. Participants must be men aged 19 to 55 with a healthy weight. The study is not yet recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE HYPERTROPHY(BPH) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Severance Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.